Finance

Lists
002675:SHE
Yantai Dongcheng Biochemicals Co Ltd
CNÂ¥12.76
+2.33%
(+0.29) 1D
Sep 21, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002675...
Open
CNÂ¥12.47
High
CNÂ¥12.78
Low
CNÂ¥12.41
Mkt. cap
10.28B
Avg. vol.
6.96M
Volume
7.37M
Dividend
0.63%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Apr 29, 2026
P/E ratio
52.25
52-wk high
CNÂ¥16.14
52-wk low
CNÂ¥12.05
EPS
CNÂ¥0.24
Shares outstanding
824.60M
No. of employees
3K
Open
CNÂ¥12.47
High
CNÂ¥12.78
Low
CNÂ¥12.41
Mkt. cap
10.28B
Avg. vol.
6.96M
Volume
7.37M
Dividend
0.63%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Apr 29, 2026
P/E ratio
52.25
52-wk high
CNÂ¥16.14
52-wk low
CNÂ¥12.05
EPS
CNÂ¥0.24
Shares outstanding
824.60M
No. of employees
3K
About Yantai Dongcheng Biochemicals Co Ltd
CEO-
Employees2.58K
FoundedDec 31, 1998
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
659.38M
697.99M
626.37M
682.55M
Cost of goods sold
274.54M
339.95M
293.57M
328.46M
Cost of revenue
274.54M
339.95M
293.57M
328.46M
Research and development expenses
67.59M
70.28M
42.01M
45.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
201.78M
183.72M
189.42M
177.78M
Operating expense
264.21M
289.10M
243.65M
245.42M
Total operating expenses
538.75M
629.04M
537.22M
573.88M
Operating income
120.63M
68.94M
89.15M
108.68M
Other non operating income
-1.14M
171.66K
-7.23M
6.41M
EBT including unusual items
69.58M
29.78M
48.41M
76.24M
EBT excluding unusual items
82.22M
13.30M
48.18M
69.47M
Income tax expense
15.06M
-108.90K
13.54M
28.12M
Effective tax rate
21.65%
-0.37%
27.97%
36.88%
Other operating expenses
-6.50M
28.66M
4.10M
14.11M
Net income
60.46M
46.51M
33.44M
60.30M
Net profit margin
9.17%
6.66%
5.34%
8.84%
Earnings per share
0.06
0.06
0.04
0.07
Interest and investment income
1.83M
1.19M
2.75M
3.81M
Interest expense
-36.22M
-43.78M
-36.48M
-36.25M
Net interest expenses
-34.39M
-42.59M
-33.74M
-32.44M
Depreciation and amortization charges
-
-
-
-
EBITDA
158.15M
113.56M
133.77M
153.53M
Gain or loss from assets sale
194.23K
-82.38K
-
-
AI content may include mistakes. Learn more
Google apps